Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 80310 | Methyl 5-bromo-2-methoxy-4-(trifluoromethyl)benzoate | 1131587-97-7 | 97% | benzoate-cas-1131587-97-7.png) |
| Coming soon! | ||||
| 80309 | Methyl 5-bromo-2,4-dimethylbenzoate | 152849-72-4 | 97% |  |
| Coming soon! | ||||
| 80308 | Methyl 5-bromo-2,4-dimethoxybenzoate | 39503-51-0 | 97% |  |
| Coming soon! | ||||
| 80306 | Methyl 5-bromo-2-methoxybenzoate | 7120-41-4 | 97% |  |
| Coming soon! | ||||
| 71903 | (+)-MK801(maleate) | 77086-22-7 | 98% by HPLC | -MK801(maleate)-cas-77086-22-7.png) |
| (+)-MK-801 is an uncompetitive antagonist of the N-Methyl-D-aspartate (NMDA) receptor | ||||
| 71902 | (-)-MK801(maleate) | 121917-57-5 | 98% by HPLC | -MK801(maleate)-cas-121917-57-5.png) |
| (-)-MK801 is a elective and non-competitive NMDA receptor antagonist. Less active ena | ||||
| 62907 | MPI-0479605 | 1246529-32-7 | >98% by HPLC |  |
| MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1.Cells treated with | ||||
| 52810 | Motesanib | 453562-69-1 | 98% |  |
| Motesanib (AMG-706) is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50 of | ||||
| 52809 | Montelukast sodium | 151767-02-1 | 98% |  |
| Montelukast Sodium(Singulair) is a potent, selective, anti-inflammatory CysLT1 recept | ||||
| 52774 | MEK162 | 606143-89-9 | 98% |  |
| MEK162(ARRY-438162; ARRY-162) is a potent inhibitor of MEK1/2 with IC50 of 12 nM. | ||||
| 52749 | MLN9708 | 1201902-80-8 | 98% |  |
| MLN9708 immediately hydrolyzed to MLN2238, which is an N-capped dipeptidyl leucine bo | ||||
| 52742 | ML347 | 1062368-49-3 | 98% |  |
| ML347(DN193719) is a highly selective ALK1/ALK2 inhibitor with IC50s of 46/32 nM; sho | ||||
| 52582 | MLS-2052 | 667463-62-9 | 98% |  |
| 6-BIO(6-Bromoindirubin-3'-oxime) is a potent and selective inhibitor of GSK-3 and | ||||
| 52827 | MLN0905 | 1228960-69-7 | 98% |  |
| MLN0905 is a small-molecule and potent inhibitor of PLK1 with IC50 of 2 nM. | ||||
| 51505 | MK 2206 | 1032350-13-2 | 98% |  |
| MK-2206 (Merck, Whitehouse Station, NJ) is an investigational oral allosteric AKT inh | ||||
| 52554 | ML161 | 423735-93-7 | 98% |  |
| ML-161 is an allosteric inhibitor ofPAR1withIC50of 0.26 M. | ||||
| 52545 | MDL-29951 | 130798-51-5 | 98% |  |
| MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H] | ||||
| 52542 | Meisoindigo | 97207-47-1 | 98% |  |
| Meisoindigo(Natura-; N-Methylisoindigotin; Dian III), a derivative of Indigo naturali | ||||
| 52525 | 3-Methyladenine (3-MA) | 5142-23-4 | 98% | -cas-5142-23-4.png) |
| 3-Methyladenine is a selective PI3K inhibitor forVps34andPI3KwithIC50of 25 M and 60 M | ||||
| 52510 | Mdivi-1 | 338967-87-6 | 98% |  |
| Mdivi-1 is a selective cell-permeable inhibitor of mitochondrial division DRP1 (dynam | ||||
| 52219 | MHY1485 | 326914-06-1 | 98% | |
| MHY1485 is a mTOR activator; inhibits the autophagic process by inhibition of fusion | ||||
| 52317 | MS436 | 1395084-25-9 | 98% |  |
| MS436 is a diazobenzene-based small-molecule inhibitor for the BRD4 bromodomains with | ||||
| 52101 | Motesanib Diphosphate (AMG-706) | 857876-30-3 | 98% | -cas-857876-30-3.png) |
| Motesanib Diphosphate (AMG-706) is a potent ATP-competitive inhibitor ofVEGFR1/2/3wit | ||||